The largest database of trusted experimental protocols

10 protocols using site directed gene mutagenesis kit

1

Validating miR-936 Binding Sites

Check if the same lab product or an alternative is used in the 5 most similar protocols
First of all, the binding sites (between miR-936 and circDOCK1 or LEF1 3′UTR) prediction was conducted using bioinformatics software circular RNA Interactome (https://circinteractome.nia.nih.gov) and TargetScan (https://www.targetscan.org). Then, these sequences were directly synthesized and cloned into psiCHECK-2 vector (Promega, Madison, WI, USA) to generate circDOCK1-wt or LEF1-wt. Meanwhile, their corresponding mutant sequences were also inserted into this vector according to the Site-directed gene mutagenesis kit (Takara), termed circDOCK1-mut or LEF1-mut. After being co-transfected with these constructed vectors and miR-936 or NC into OS cells for 48 h, the luciferase activities in cell lysates were analyzed by a dual-luciferase reporter assay kit (Promega).
+ Open protocol
+ Expand
2

Validating miRNA-Target Interactions

Check if the same lab product or an alternative is used in the 5 most similar protocols
In this assay, the partial sequence in hsa_circ_0005085 or 3′ untranslated region (3′UTR) of LAMC1 mRNA, including the binding sits with miR‐186‐5p, was directly amplified and inserted into pmirGLO (Promega, Madison, WI, USA), generating hsa_circ_0005085 wild type (wt) or LAMC1 3′UTR wt. In addition, the corresponding mutant (mut) sequence in hsa_circ_0005085 or LAMC1 was also amplified and cloned into pmirGLO (Promega) to obtain hsa_circ_0005085 mut or LAMC1 3′UTR using Site‐directed gene mutagenesis kit (TaKaRa). 293T cells were planted into 48‐well plates overnight, then co‐transfected with these reporter‐constructed plasmids and mimic NC or miR‐186‐5p mimic for 48 h. Then, cells were collected for luciferase activity examination using a dual‐luciferase reporter assay system (Promega). Relative luciferase activity was normalized to Renilla luciferase activity.
+ Open protocol
+ Expand
3

Dual-Luciferase Assay Validates circ-MEMO1-miR-101-3p Interaction

Check if the same lab product or an alternative is used in the 5 most similar protocols
StarBase database was used to predict the interactions of circ-MEMO1-miRNAs and miR-101-3p-mRNAs. Dual-luciferase reporter assay was used to test the target relationship between miR-101-3p and circ-MEMO1 or KRAS. The partial sequence in circ-MEMO1 or the 3′ untranslated region (3′ UTR) of KRAS messenger RNA (mRNA), containing the binding sites with miR-101-3p, was directly amplified and inserted into pGL3 luciferase reporter vector (Promega, Madison, WI, United States), termed as circ-MEMO1-wt or KRAS 3′ UTR wt. Meanwhile, the corresponding mutant sequence in circ-MEMO1 or KRAS was also amplified and inserted into pGL3 luciferase reporter vector (Promega) to generate circ-MEMO1-mut or KRAS 3′ UTR mut using Site-directed gene mutagenesis kit (Takara, Dalian, China). After co-transfecting these reporter constructed plasmids (50 ng) and miR-NC or miR-101-3p (20 nM) into NSCLC cells for 48 h, the luciferase activity was detected with the dual-luciferase reporter assay system (Promega) using the luminometer (Plate Chameleon V, Hidex, Finland). Firefly luciferase activity was normalized to Renilla luciferase intensity. The experiment was repeated three times.
+ Open protocol
+ Expand
4

Regulation of KLF4 by miR-140-3p

Check if the same lab product or an alternative is used in the 5 most similar protocols
The 3′ untranslated region (UTR) fragments of KLF4 containing the predicted binding sites of miR-140-3p were synthesized and cloned into the psiCHECK-2 dual luciferase reporter plasmid (Promega Corporation); this reporter plasmid was designated KLF4 wild-type. Mutation in the putative miR-140-3p target sequences in the 3′UTR of KLF4 was generated using a site-directed gene mutagenesis kit (Takara Bio, Inc.); this reporter plasmid was designated KLF4 mutant-type. For the luciferase reporter assay, HUVECs were seeded into six-well plates and co-transfected with 200 ng KLF4 wild-type or KLF4 mutant-type and 100 nM miR-NC or miR-140-3p mimics using Lipofectamine 2000 (Invitrogen; Thermo Fisher Scientific, Inc.) reagent, following with the manufacturer's protocol. After 24 h, the cell lysates were assayed for luciferase activity using the Luciferase Assay System (Promega Corporation). Luciferase activity was measured on a luminescence counter (Centro XS3 LB 960; Berthold Technologies). The relative luciferase activity was expressed as the ratio of firefly luciferase to Renilla luciferase activity.
+ Open protocol
+ Expand
5

Validation of CircRNA-miRNA-mRNA Interactions

Check if the same lab product or an alternative is used in the 5 most similar protocols
The targets of circ_0007841 and miR-338-3p were predicted by circinteractome and targetscan software, respectively.
The wild-type partial sequence in circ_0007841 that predicted to bind to miR-338-3p, along with the mutant-type sequence with miR-338-3p in circ_0007841 that was synthesized through using Site-directed gene mutagenesis kit (Takara, Dalian, China), was amplified and cloned into pGL3 luciferase reporter vector (Promega, Madison, WI, USA), termed as circ_0007841 WT or circ_0007841 MUT. MM cells were co-transfected with 10 nM miR-NC or miR-338-3p and 40 ng circ_0007841 WT or circ_0007841 MUT. After 48-h transfection, MM cells were harvested and the luciferase activity was detected with the dual-luciferase reporter assay system kit (Promega) using the luminometer (Plate Chameleon V, Hidex, Finland) according to the manufacturer’s instructions. Firefly luciferase activity in each group was normalized to Renilla fluorescence intensity.
The wild-type fragment of BRD4 3′ untranslated region (3′UTR) that predicted to bind to miR-338-3p and the mutant type fragment of BRD4 3′UTR were also amplified and inserted into pGL3 luciferase reporter vector (Promega) to generate BRD4 3′UTR WT and BRD4 3′UTR MUT. Co-transfection of MM cells with BRD4 3′UTR WT or BRD4 3′UTR MUT and miR-NC or miR-338-3p was conducted following the similar procedure.
+ Open protocol
+ Expand
6

Validation of miR-486-3p Binding Sites

Check if the same lab product or an alternative is used in the 5 most similar protocols
Based on the analysis of LncBase (https://diana.e-ce.uth.gr/lncbasev3/interactions) and TargetScan (http://www.targetscan.org), the possible binding sites were acquired. For wild-type (WT) luciferase reporter constructs (AGAP2-AS1WT and TGF-β1 3′UTR WT), the fragments of AGAP2-AS1 or TGF-β1 3′UTR containing the predicted binding sites with miR-486-3p were cloned into pmirGLO vector (Promega). In parallel, mutant (MUT) constructs (AGAP2-AS1MUT and TGF-β1 3′UTR MUT) were obtained using Site-directed gene mutagenesis kit (Takara, #638943). Whereafter, these constructs were co-transfected into 293T cells with miR-486-3p or miR-NC, followed by the analysis of dual-luciferase reporter assay kit (Promega, #E1910).
+ Open protocol
+ Expand
7

Dual-Luciferase Assay for miRNA-mRNA Interactions

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Xist fragment containing the putative miR-32-5p binding site was cloned into the pmirGlo vector (Promega, United States) and named WT Xist. Mutation of the putative miR-32-5p target sequence in the 3-UTR of Xist was generated using a site-directed gene mutagenesis kit (Takara) and named MUT Xist. HEK-293T cells were co-transfected separately with the two constructs or empty vector and miR-32-5p mimics or inhibitors. For miR-32-5p and Notch-1 interaction, the putative and mutated miR-32-5p target binding sequences in Notch-1 were synthesized and cells were co-transfected with the WT or MUT Notch-1 reporter gene plasmid or pmirGlo plasmids using Lipofectamine® 2000 (Invitrogen). At 48 h post-transfection, cells were harvested and the firefly luciferase activity was measured using a dual-luciferase reporter assay system (Promega) and normalized to Renilla luciferase activity (Jin et al., 2018 (link); Hu et al., 2019 (link)).
+ Open protocol
+ Expand
8

Validating miRNA-mRNA Interactions

Check if the same lab product or an alternative is used in the 5 most similar protocols
The bioinformatics software StarBase (https://starbase.sysu.edu.cn/) was used to predict the potential-binding sites of PEG10-miRNA interactions and miR-449a-miRNA interactions. The target interactions between miR-449a and PEG10 or RPS2 were confirmed by Dual-luciferase reporter assay. The predictive wild type (WT) of binding sequences with miR-449a in PEG10 and RPS2 were amplified and cloned into pmirGLO vector (Promega), called as PEG10-WT and RPS2-WT. Simultaneously, the mutant type (MUT) of binding sequences in PEG10 and RPS2 were also synthesized by site-directed gene mutagenesis kit (Takara, Japan) and inserted into pmirGLO vector (Promega), named as PEG10-MUT and RPS2-WT. SK-N-BE (2) and SH-SY5Y cells were inoculated into 24-well plates for 24 h, then transfected with 50 ng of reporter plasmids along with 20 nM of miR-449a or mimic NC with Lipofectamine 3000 (Invitrogen). After transfection for 48 h, cells were lysed, luciferase activities were assessed by a Dual-Luciferase Reporter Assay Kit (Promega) in light of the instructions of manufacturer and normalized with Renilla luciferase as control [28 (link)].
+ Open protocol
+ Expand
9

Investigating miR-539 Regulation of EGFR

Check if the same lab product or an alternative is used in the 5 most similar protocols
The 3′-UTR of human EGFR, including the complementary binding site of miR-539, was cloned downstream of the firefly cassette of the psiCHECK-2 dual-luciferase reporter plasmid (Promega, WI, USA) to construct the psiCHECK-2-EGFR wild-type (WT) luciferase reporter plasmid. The complementary binding site was then mutated using a site-directed gene mutagenesis kit (TaKaRa, Japan). The mutated EGFR 3′-UTR was also inserted into the psiCHECK-2 plasmid to generate the psiCHECK-2-EGFR mutant (MUT) luciferase reporter plasmid. MDA-MB-231 and MCF7 cells were co-transfected with psiCHECK-2-EGFR (WT) or (MUT) and miR-539 mimics or the mimic control using Lipofectamine 2000 according to the manufacturer’s protocols. Forty-eight hours after transfection, a dual-luciferase reporter assay system (Promega, WI, USA) was used to detected the firefly and Renilla luciferase activities. The firefly luciferase activities were normalized to the Renilla luciferase activities.
+ Open protocol
+ Expand
10

Dual-Luciferase Assay for miRNA-CircRNA Interactions

Check if the same lab product or an alternative is used in the 5 most similar protocols
The targets of circ_0007841 and miR-338-3p were predicted by circinteractome and targetscan software, respectively.
The wild-type partial sequence in circ_0007841 that predicted to bind to miR-338-3p, along with the mutant-type sequence with miR-338-3p in circ_0007841 that was synthesized through using Site-directed gene mutagenesis kit (Takara, Dalian, China), was ampli ed and cloned into pGL3 luciferase reporter vector (Promega, Madison, WI, USA), termed as circ_0007841 WT or circ_0007841 MUT. MM cells were co-transfected with 10 nM miR-NC or miR-338-3p and 40 ng circ_0007841 WT or circ_0007841 MUT. After 48-h transfection, MM cells were harvested and the luciferase activity was detected with the dualluciferase reporter assay system kit (Promega) using the luminometer (Plate Chameleon V, Hidex, Finland) according to the manufacturer's instructions. Fire y luciferase activity in each group was normalized to Renilla uorescence intensity.
The wild-type fragment of BRD4 3' untranslated region (3'UTR) that predicted to bind to miR-338-3p and the mutant type fragment of BRD4 3'UTR were also ampli ed and inserted into pGL3 luciferase reporter vector (Promega) to generate BRD4 3'UTR WT and BRD4 3'UTR MUT. Co-transfection of MM cells with BRD4 3'UTR WT or BRD4 3'UTR MUT and miR-NC or miR-338-3p was conducted following the similar procedure.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!